The renin rise with aliskiren: It's simply stoichiometry

被引:28
作者
Danser, A. H. Jan [1 ]
Charney, Alan [2 ]
Feldman, David L. [2 ]
Nussberger, Juerg [3 ]
Fisher, Naomi [4 ,5 ,6 ]
Hollenberg, Norman [4 ,5 ,6 ]
机构
[1] Erasmus MC, Dept Internal Med, Div Vasc Pharmacol & Metab, Rotterdam, Netherlands
[2] Nova Pharmaceut Corp, E Hanover, NJ USA
[3] CHU Vaudois, Lausanne, Switzerland
[4] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1161/HYPERTENSIONAHA.108.109967
中图分类号
R6 [外科学];
学科分类号
1002 [临床医学]; 100210 [外科学];
摘要
引用
收藏
页码:E27 / E28
页数:2
相关论文
共 5 条
[1]
Interpretation of plasma renin concentration in patients receiving aliskiren therapy [J].
Campbell, Duncan J. .
HYPERTENSION, 2008, 51 (01) :15-18
[2]
Renin, prorenin and the putative (pro)renin receptor [J].
Danser, AHJ ;
Deinum, J .
HYPERTENSION, 2005, 46 (05) :1069-1076
[3]
Fisher ND, 2007, CIRCULATION, V116, P556
[4]
Ménard J, 2007, J HYPERTENS, V25, P1775
[5]
Aliskiren, the first renin inhibitor for treating hypertension: Reactive renin secretion may limit its effectiveness [J].
Sealey, Jean E. ;
Laragh, John H. .
AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (05) :587-597